My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Enfermería Nefrológica
On-line version ISSN 2255-3517Print version ISSN 2254-2884
Abstract
FERNANDEZ-PEREZ, Mónica et al. Analysis of the mupirocin application in the healthy exit site in peritoneal dialysis. Enferm Nefrol [online]. 2022, vol.25, n.4, pp.337-342. Epub Mar 13, 2023. ISSN 2255-3517. https://dx.doi.org/10.37551/52254-28842022034.
Introduction:
Outflow tract infection is an important complication in peritoneal dialysis, mainly because it can progress to tunelitis and/or catheter-dependent peritoneal infection that often leads to catheter removal.
Objective:
To analyse the mupirocin application in the management of the healthy exit site and the impact on the infection rate and the percentage of catheter-dependent peritoneal infections.
Material and Method:
Retrospective observational study in a provincial peritoneal dialysis unit. Patients over 18 years of age who underwent peritoneal dialysis at home from 01/01/2019 to 31/12/2021 were included. Variables analysed were: sex, yearly orifice infection rate, responsible germs, catheter-dependent peritoneal infections and appearance of resistance. Data were obtained from the unit’s annual registry.
Results:
Twice-weekly mupirocin application in healthy peritoneal catheter exit site care has decreased the rate of exit site infections from 0.47 episode/patient/year in 2019 to 0.32 in 2020 and 0.16 in 2021, decreasing the percentage of catheter-dependent peritoneal infections from 38% in 2019 to 30% in 2020 and 8% in 2021. No resistance has been observed.
Conclusions:
Mupirocin application in our unit appears to be effective in reducing exit site infections and catheter-dependent peritoneal infections.
Keywords : peritoneal dialysis; catheter; exit site infection; tunelitis; catheter-dependent peritoneal infection; mupirocin.